MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wafford, K. A.
Right arrow Articles by Whiting, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wafford, K. A.
Right arrow Articles by Whiting, P. J.

Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit

KA Wafford, SA Thompson, D Thomas, J Sikela, AS Wilcox and PJ Whiting

Merck Sharp & Dohme Research Laboratories, Harlow, Essex, UK. keith_wafford@merck.com

The alpha subunits are an important determinant of the pharmacology of gamma-aminobutyric acidA (GABAA) receptors with respect to agonists, antagonists, and modulatory compounds, particularly the benzodiazepines. The alpha 4 subunit is the least abundant subunit in the brain and the most similar in deduced primary amino acid sequence to the alpha 6 subunit. We demonstrate that the human alpha 4 subunit forms a functional receptor when expressed with beta gamma 2, demonstrating some properties similar to alpha 6 beta gamma 2 and some properties more akin to alpha 1 beta gamma 2. It also exhibited some properties that were unlike any other alpha subunit-containing receptor. GABA affinity seemed to be identical to that of the alpha 1 beta 1 gamma 2 receptor; however, the partial agonists 4,5,6,7- tetrahydroisoxazolo-[5,4-c]pyridin-3-ol and piperidine-4-sulfonic acid showed lower efficacy than at either alpha 1 beta 1 gamma 2 or alpha 6 beta 1 gamma 2. Benzodiazepine pharmacology of alpha 4-containing receptors was similar to that of alpha 6-containing receptors with the exception of dimethoxy-4-ethyl-beta-carboline-3-carboxylate, which behaved as a partial inverse agonist. Pentobarbital potentiated alpha 4 beta 1 gamma 2 receptor GABA responses to a level comparable with alpha 6 beta 1 gamma 2 (approximately 700% of EC20); however, unlike alpha 6 beta 1 gamma 2 receptors, it did not elicit any direct activation of the receptor. Propofol also potentiated alpha 4 beta 1 gamma 2 GABA responses but to a level more comparable to that of alpha 1 beta 1 gamma 2, suggesting that these compounds act via different sites. Unlike other subunit combinations, propofol did not elicit a direct activation of the receptor. These results suggest that the mechanism for direct activation of the GABAA receptor by pentobarbital and propofol is absent on alpha 4-containing receptors. Furosemide, which non-competitively inhibits the GABAA receptor, showed 700-fold selectivity for alpha 6 beta 3 gamma 2 receptors over alpha 1-, alpha 2- , alpha 3-, and alpha 5-containing receptors and exhibited selectivity for alpha 4 beta 3 gamma 2 receptors (> 50-fold). These experiments reveal a unique pharmacology for alpha 4-containing receptors with some similarities to both alpha 6- and alpha 1-containing receptors.

Volume 50, Issue 3, pp. 670-678, 09/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. Sun, Z. Mtchedlishvili, A. Erisir, and J. Kapur
Diminished Neurosteroid Sensitivity of Synaptic Inhibition and Altered Location of the {alpha}4 Subunit of GABAA Receptors in an Animal Model of Epilepsy
J. Neurosci., November 14, 2007; 27(46): 12641 - 12650.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. L. Payne, W. M. Connelly, J. H. Ives, R. Lehner, B. Furtmuller, W. Sieghart, P. Tiwari, J. M. Lucocq, G. Lees, and C. L. Thompson
GABAA {alpha}6-Containing Receptors Are Selectively Compromised in Cerebellar Granule Cells of the Ataxic Mouse, Stargazer
J. Biol. Chem., October 5, 2007; 282(40): 29130 - 29143.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. J. Bailey, M. A. Ravier, and G. A. Rutter
Glucose-Dependent Regulation of {gamma}-Aminobutyric Acid (GABAA) Receptor Expression in Mouse Pancreatic Islet {alpha}-Cells
Diabetes, February 1, 2007; 56(2): 320 - 327.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Yamashita, W. Marszalec, J. Z. Yeh, and T. Narahashi
Effects of Ethanol on Tonic GABA Currents in Cerebellar Granule Cells and Mammalian Cells Recombinantly Expressing GABAA Receptors
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 431 - 438.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. C. Drafts and J. L. Fisher
Identification of Structures within GABAA Receptor {alpha} Subunits That Regulate the Agonist Action of Pentobarbital
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1094 - 1101.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
T. A. Lovick
Plasticity of GABAA receptor subunit expression during the oestrous cycle of the rat: implications for premenstrual syndrome in women
Exp Physiol, July 1, 2006; 91(4): 655 - 660.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. i Storustovu and B. Ebert
Pharmacological Characterization of Agonists at {delta}-Containing GABAA Receptors: Functional Selectivity for Extrasynaptic Receptors Is Dependent on the Absence of {gamma}2
J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1351 - 1359.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. Mtchedlishvili and J. Kapur
High-Affinity, Slowly Desensitizing GABAA Receptors Mediate Tonic Inhibition in Hippocampal Dentate Granule Cells
Mol. Pharmacol., February 1, 2006; 69(2): 564 - 575.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. R. Atack, K. A. Wafford, S. J. Tye, S. M. Cook, B. Sohal, A. Pike, C. Sur, D. Melillo, L. Bristow, F. Bromidge, et al.
TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an Agonist Selective for {alpha}2- and {alpha}3-Containing GABAA Receptors, Is a Nonsedating Anxiolytic in Rodents and Primates
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 410 - 422.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Dias, W. F. A. Sheppard, R. L. Fradley, E. M. Garrett, J. L. Stanley, S. J. Tye, S. Goodacre, R. J. Lincoln, S. M. Cook, R. Conley, et al.
Evidence for a Significant Role of {alpha}3-Containing GABAA Receptors in Mediating the Anxiolytic Effects of Benzodiazepines
J. Neurosci., November 16, 2005; 25(46): 10682 - 10688.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. S. Mangan, C. Sun, M. Carpenter, H. P. Goodkin, W. Sieghart, and J. Kapur
Cultured Hippocampal Pyramidal Neurons Express Two Kinds of GABAA Receptors
Mol. Pharmacol., March 1, 2005; 67(3): 775 - 788.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Ma, L. Song, G. E. Radoi, and N. L. Harrison
Transcriptional Regulation of the Mouse Gene Encoding the {alpha}-4 Subunit of the GABAA Receptor
J. Biol. Chem., September 24, 2004; 279(39): 40451 - 40461.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. L. Boehm II, L. Peden, R. A. Harris, and Y. A. Blednov
Deletion of the fyn-Kinase Gene Alters Sensitivity to GABAergic Drugs: Dependence on {beta}2/{beta}3 GABAA Receptor Subunits
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1154 - 1159.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. Akk, J. Bracamontes, and J. H. Steinbach
Activation of GABAA receptors containing the {alpha}4 subunit by GABA and pentobarbital
J. Physiol., April 15, 2004; 556(2): 387 - 399.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Sanna, M. C. Mostallino, F. Busonero, G. Talani, S. Tranquilli, M. Mameli, S. Spiga, P. Follesa, and G. Biggio
Changes in GABAA Receptor Gene Expression Associated with Selective Alterations in Receptor Function and Pharmacology after Ethanol Withdrawal
J. Neurosci., December 17, 2003; 23(37): 11711 - 11724.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Wallner, H. J. Hanchar, and R. W. Olsen
From The Cover: Ethanol enhances {alpha}4{beta}3{delta} and {alpha}6{beta}3{delta} {gamma}-aminobutyric acid type A receptors at low concentrations known to affect humans
PNAS, December 9, 2003; 100(25): 15218 - 15223.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. T. Sinkkonen, S. Mansikkamaki, T. Moykkynen, H. Luddens, M. Uusi-Oukari, and E. R. Korpi
Receptor Subtype-Dependent Positive and Negative Modulation of GABAA Receptor Function by Niflumic Acid, a Nonsteroidal Anti-Inflammatory Drug
Mol. Pharmacol., September 1, 2003; 64(3): 753 - 763.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Gulinello and S. S. Smith
Anxiogenic Effects of Neurosteroid Exposure: Sex Differences and Altered GABAA Receptor Pharmacology in Adult Rats
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 541 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
F.-C. Hsu, R. Waldeck, D. S. Faber, and S. S. Smith
Neurosteroid Effects on GABAergic Synaptic Plasticity in Hippocampus
J Neurophysiol, April 1, 2003; 89(4): 1929 - 1940.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
F.-C. Hsu and S. S. Smith
Progesterone Withdrawal Reduces Paired-Pulse Inhibition in Rat Hippocampus: Dependence on GABAA Receptor alpha 4 Subunit Upregulation
J Neurophysiol, January 1, 2003; 89(1): 186 - 198.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
B. K. Hoffpauir and E. L. Gleason
Activation of mGluR5 Modulates GABAA Receptor Function in Retinal Amacrine Cells
J Neurophysiol, October 1, 2002; 88(4): 1766 - 1776.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. L. Fisher
Amiloride Inhibition of gamma -Aminobutyric AcidA Receptors Depends upon the alpha Subunit Subtype
Mol. Pharmacol., June 1, 2002; 61(6): 1322 - 1328.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. E. Adkins, G. V. Pillai, J. Kerby, T. P. Bonnert, C. Haldon, R. M. McKernan, J. E. Gonzalez, K. Oades, P. J. Whiting, and P. B. Simpson
alpha 4beta 3delta GABAA Receptors Characterized by Fluorescence Resonance Energy Transfer-derived Measurements of Membrane Potential
J. Biol. Chem., October 12, 2001; 276(42): 38934 - 38939.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. R. McMahon, L. R. Gerak, and C. P. France
Potency of Positive gamma -Aminobutyric AcidA Modulators to Substitute for a Midazolam Discriminative Stimulus in Untreated Monkeys Does Not Predict Potency to Attenuate a Flumazenil Discriminative Stimulus in Diazepam-Treated Monkeys
J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1227 - 1235.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Fujii and S. H. Mellon
Regulation of Uterine {{gamma}}-Aminobutyric AcidA Receptor Subunit Expression throughout Pregnancy
Endocrinology, May 1, 2001; 142(5): 1770 - 1777.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
A. J. Smith, L. Alder, J. Silk, C. Adkins, A. E. Fletcher, T. Scales, J. Kerby, G. Marshall, K. A. Wafford, R. M. McKernan, et al.
Effect of alpha Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant gamma -Aminobutyric AcidA Receptors Determined Using 36Cl Ion Flux
Mol. Pharmacol., April 16, 2001; 59(5): 1108 - 1118.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
A. S. Cohen, D. D. Lin, and D. A. Coulter
Protracted Postnatal Development of Inhibitory Synaptic Transmission in Rat Hippocampal Area CA1 Neurons
J Neurophysiol, November 1, 2000; 84(5): 2465 - 2476.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Poelchen, W. R. Proctor, and T. V. Dunwiddie
The In Vitro Ethanol Sensitivity of Hippocampal Synaptic gamma -Aminobutyric AcidA Responses Differs in Lines of Mice and Rats Genetically Selected for Behavioral Sensitivity or Insensitivity to Ethanol
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 741 - 746.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
E. Louiset, R. McKernan, W. Sieghart, and H. Vaudry
Subunit Composition and Pharmacological Characterization of {gamma}-Aminobutyric Acid Type A Receptors in Frog Pituitary Melanotrophs
Endocrinology, March 1, 2000; 141(3): 1083 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. M. J. Dunn, M. Davies, A. L. Muntoni, and J. J. Lambert
Mutagenesis of the Rat alpha 1 Subunit of the gamma -Aminobutyric AcidA Receptor Reveals the Importance of Residue 101 in Determining the Allosteric Effects of Benzodiazepine Site Ligands
Mol. Pharmacol., October 1, 1999; 56(4): 768 - 774.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
T. R. Neelands, J. Zhang, and R. L. Macdonald
GABAA Receptors Expressed in Undifferentiated Human Teratocarcinoma NT2 Cells Differ from Those Expressed by Differentiated NT2-N Cells
J. Neurosci., August 15, 1999; 19(16): 7057 - 7065.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Sur, S. J. Farrar, J. Kerby, P. J. Whiting, J. R. Atack, and R. M. McKernan
Preferential Coassembly of alpha 4 and delta  Subunits of the gamma -Aminobutyric AcidA Receptor in Rat Thalamus
Mol. Pharmacol., July 1, 1999; 56(1): 110 - 115.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
W. Jarolimek, A. Lewen, and U. Misgeld
A Furosemide-Sensitive K+-Cl- Cotransporter Counteracts Intracellular Cl- Accumulation and Depletion in Cultured Rat Midbrain Neurons
J. Neurosci., June 15, 1999; 19(12): 4695 - 4704.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S.A. Thompson, S.A. Arden, G. Marshall, P.B. Wingrove, P.J. Whiting, and K.A. Wafford
Residues in Transmembrane Domains I and II Determine gamma -Aminobutyric Acid Type AA Receptor Subtype-Selective Antagonism by Furosemide
Mol. Pharmacol., June 1, 1999; 55(6): 993 - 999.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
J. Kapur and R. L. Macdonald
Postnatal Development of Hippocampal Dentate Granule Cell gamma -Aminobutyric AcidA Receptor Pharmacological Properties
Mol. Pharmacol., March 1, 1999; 55(3): 444 - 452.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
T. R. Neelands, J. L. Fisher, M. Bianchi, and R. L. Macdonald
Spontaneous and gamma -Aminobutyric Acid (GABA)-Activated GABAA Receptor Channels Formed by epsilon  Subunit-Containing Isoforms
Mol. Pharmacol., January 1, 1999; 55(1): 168 - 178.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
C. Sur, K. Quirk, D. Dewar, J. Atack, and R. McKernan
Rat and Human Hippocampal alpha 5 Subunit-Containing gamma -Aminobutyric AcidA Receptors Have alpha 5beta 3gamma 2 Pharmacological Characteristics
Mol. Pharmacol., November 1, 1998; 54(5): 928 - 933.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
S. S. Smith, Q. H. Gong, X. Li, M. H. Moran, D. Bitran, C. A. Frye, and F.-C. Hsu
Withdrawal from 3alpha -OH-5alpha -Pregnan-20-One Using a Pseudopregnancy Model Alters the Kinetics of Hippocampal GABAA-Gated Current and Increases the GABAA Receptor alpha 4 Subunit in Association with Increased Anxiety
J. Neurosci., July 15, 1998; 18(14): 5275 - 5284.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. R. Neelands, L. J. Greenfield Jr, J. Zhang, R. S. Turner, and R. L. Macdonald
GABAA Receptor Pharmacology and Subtype mRNA Expression in Human Neuronal NT2-N Cells
J. Neurosci., July 1, 1998; 18(13): 4993 - 5007.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
E. A. Barnard, P. Skolnick, R. W. Olsen, H. Mohler, W. Sieghart, G. Biggio, C. Braestrup, A. N. Bateson, and S. Z. Langer
International Union of Pharmacology. XV. Subtypes of gamma -Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Structure and Receptor Function
Pharmacol. Rev., June 1, 1998; 50(2): 291 - 314.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. D. Krasowski, V. V. Koltchine, C. E. Rick, Q. Ye, S. E. Finn, and N. L. Harrison
Propofol and Other Intravenous Anesthetics Have Sites of Action on the gamma -Aminobutyric Acid Type A Receptor Distinct from That for Isoflurane
Mol. Pharmacol., March 1, 1998; 53(3): 530 - 538.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
M. I. Banks, T.-B. Li, and R. A. Pearce
The Synaptic Basis of GABAA,slow
J. Neurosci., February 15, 1998; 18(4): 1305 - 1317.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Ebert, S. A. Thompson, K. Saounatsou, R. McKernan, P. Krogsgaard-Larsen, and K. A. Wafford
Differences in Agonist/Antagonist Binding Affinity and Receptor Transduction Using Recombinant Human gamma -Aminobutyric Acid Type A Receptors
Mol. Pharmacol., December 1, 1997; 52(6): 1150 - 1156.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
J. L. Fisher, J. Zhang, and R. L. Macdonald
The Role of alpha 1 and alpha 6 Subtype Amino-Terminal Domains in Allosteric Regulation of gamma -Aminobutyric Acida Receptors
Mol. Pharmacol., October 1, 1997; 52(4): 714 - 724.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics